Many of the DEGs were involved in ferroptosis (Ptgs2), enhanced T-cell function (Lef1), regulators of EMT (Zeb1, Zeb2, Vimentin, and Sfrp2), and fibrosis (Col1α1 and Acta2) in the tumor microenvironment. The gene discussed is SFRP2; the disease is neoplasm.